HAX’s VC-Founder Industry Hard Tech Matchup is now accepting applications. Register today!

Reactosome is a synthetic cell platform that enables an efficient new class of nucleic acid therapies, unlocking treatments for complex diseases like solid cancers and age-related disorders by affecting 10x more genes than traditional methods